SCHEMBL6528675

SCHEMBL6528675

Cc1noc(C(O)[C@@H]2CCCN2C(=O)OC(C)(C)C)n1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
GPR119 Q8TDV5 2/20 0.40
USP30 Q70CQ3 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PTPN1 P18031 1/20 0.38
PDE8B O95263 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29181968 0.83 ALDH1A1 (0.40) ALDH1A1GPR119USP30L3MBTL1HSD17B10
SCHEMBL6528830 0.83 ALDH1A1 (0.40) ALDH1A1GPR119USP30L3MBTL1HSD17B10
SCHEMBL13805609 0.78 ALDH1A1 (0.54) ALDH1A1GPR119L3MBTL1TSHRMEN1
SCHEMBL24928632 0.76 EPHX2 (0.42) ALDH1A1L3MBTL1TSHRMEN1KMT2A
SCHEMBL4153235 0.76 NPC1 (0.45) ALDH1A1GPR119USP30L3MBTL1HSD17B10
SCHEMBL6529234 0.76 HSD17B10 (0.47) ALDH1A1USP30L3MBTL1HSD17B10TSHR
SCHEMBL22139321 0.75 HSD17B10 (0.49) ALDH1A1HSD17B10MEN1KMT2ALMNA
SCHEMBL20256229 0.75 HSD17B10 (0.49) ALDH1A1HSD17B10MEN1KMT2ALMNA
SCHEMBL4143386 0.75 GPR119 (0.47) GPR119HSD17B10NPC1
SCHEMBL14641475 0.75 ALDH1A1 (0.50) ALDH1A1L3MBTL1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037828-A1 NOVEL INHIBITORS OF DPP-IV, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT LG LIFE SCIENCES LTD. (KR) 2005-04-28 WO disclosed